Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

38.66
-1.0000-2.52%
Post-market: 39.000.3400+0.88%19:55 EDT
Volume:4.64M
Turnover:182.75M
Market Cap:4.30B
PE:-27.02
High:41.14
Open:39.80
Low:38.35
Close:39.66
52wk High:41.14
52wk Low:8.46
Shares:111.19M
Float Shares:82.57M
Volume Ratio:0.53
T/O Rate:5.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4309
EPS(LYR):-1.5305
ROE:-74.73%
ROA:-44.13%
PB:17.97
PE(LYR):-25.26

Loading ...

Amylyx director Karen Firestone acquires $51,338 of common shares

Reuters
·
May 27

Do HELIOS Data Shift Amylyx (AMLX) From ALS Setback To Broader Rare-Disease Strategy Reboot?

Simply Wall St.
·
May 22

Amylyx announces publication of Phase 2 open-label HELIOS trial data

TIPRANKS
·
May 16

Amylyx posts Phase 2 HELIOS data showing AMX0035 benefits in Wolfram syndrome

Reuters
·
May 16

Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label Helios Trial Data for Amx0035 in the Journal of Clinical Investigation

THOMSON REUTERS
·
May 16

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 11

Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), BioAge Labs, Inc. (BIOA) and Pharvaris (PHVS)

TIPRANKS
·
May 10

Stock Track | Amylyx Pharmaceuticals Plummets 8.16% Intraday on Wider-Than-Expected Q1 Loss

Stock Track
·
May 08

Amylyx Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Amylyx Pharmaceuticals Q1 net loss widens more than expected on higher R&D costs

Reuters
·
May 07

Earnings Flash (AMLX) Amylyx Posts Q1 Loss $0.37 a Share, vs. FactSet Est of $0.35 Loss

MT Newswires Live
·
May 07

Amylyx Pharma Q1 EPS $(0.37), Inline, Cash, Cash Equivalents, And Short-Term Investments Were $279.8M, With Expected Cash Runway into 2028

Benzinga Earnings
·
May 07

Amylyx Q1 net loss widens to $41.3 million

Reuters
·
May 07

BRIEF-Amylyx Pharmaceuticals Q1 EPS USD -0.37 Vs. IBES Estimate USD -0.33

Reuters
·
May 07

Amylyx Pharmaceuticals Inc - Cash Runway Expected to Fund Operations Into 2028

THOMSON REUTERS
·
May 07

Press Release: Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results

Dow Jones
·
May 07

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 07

Amylyx management participates in Bank of America Health Care Conference fireside chat

Reuters
·
May 06

Amylyx Pharmaceuticals Announces U.S. Expanded Access Program for Adults With Post-Bariatric Hypoglycemia

THOMSON REUTERS
·
May 05

Amylyx Pharmaceuticals Inc - Avexitide Phase 3 Lucidity Trial Topline Data Readout Anticipated in Q3 2026

THOMSON REUTERS
·
May 05